ArticleTherapeutic advances in ophthalmology
Clinical impact of the 0.2 µg/day fluocinolone acetonide intravitreal implant: outcomes from the ILUVIEN
Angela Carneiro et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
cites it